| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/SREP26758 |
| P8608 | Fatcat ID | release_orrudcdhy5ew5g7nbf7326ufli |
| P932 | PMC publication ID | 4882625 |
| P698 | PubMed publication ID | 27230293 |
| P50 | author | Valérie Vingtdeux | Q30421269 |
| Luc Buée | Q56526742 | ||
| Benoit Viollet | Q42482187 | ||
| Peter Davies | Q42689763 | ||
| P2093 | author name string | Philippe Marambaud | |
| Haitian Zhao | |||
| Pallavi Chandakkar | |||
| Claudia Marinangeli | |||
| Sébastien Didier | |||
| Manon Domise | |||
| P2860 | cites work | Phosphorylation of microtubule-associated protein tau by AMPK-related kinases | Q24292882 |
| MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption | Q24313701 | ||
| The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity | Q24554361 | ||
| Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells | Q24655644 | ||
| Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's Disease | Q26801929 | ||
| Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model | Q28115206 | ||
| Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration | Q28140796 | ||
| Metabolic regulation of neuronal plasticity by the energy sensor AMPK | Q28472728 | ||
| The peptidylprolyl cis/trans-isomerase Pin1 modulates stress-induced dephosphorylation of Tau in neurons. Implication in a pathological mechanism related to Alzheimer disease | Q28583038 | ||
| Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system | Q28587570 | ||
| Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits | Q30478477 | ||
| Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. | Q30984127 | ||
| Two-dimensional electrophoresis of tau mutants reveals specific phosphorylation pattern likely linked to early tau conformational changes. | Q33418581 | ||
| AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism. | Q33726605 | ||
| Inhibition of AMP-activated protein kinase signaling alleviates impairments in hippocampal synaptic plasticity induced by amyloid β. | Q34123865 | ||
| Involvement of AMP-activated-protein-kinase (AMPK) in neuronal amyloidogenesis | Q34296550 | ||
| Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling | Q34411340 | ||
| AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer’s disease and other tauopathies | Q34696305 | ||
| Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models | Q35053059 | ||
| Nuclear translocation of AMPK-alpha1 potentiates striatal neurodegeneration in Huntington's disease | Q35130191 | ||
| Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease | Q35223831 | ||
| Tau phosphorylation at serine 396 residue is required for hippocampal LTD | Q35316005 | ||
| AMP-activated protein kinase (AMPK) is a tau kinase, activated in response to amyloid β-peptide exposure. | Q54622561 | ||
| Phosphorylation of tau protein by recombinant GSK-3beta: pronounced phosphorylation at select Ser/Thr-Pro motifs but no phosphorylation at Ser262 in the repeat domain | Q60603639 | ||
| Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5 | Q60603655 | ||
| Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau | Q67894826 | ||
| Microtubule-associated proteins regulate microtubule function as the track for intracellular membrane organelle transports | Q73266498 | ||
| Characterization of pathology in transgenic mice over-expressing human genomic and cDNA tau transgenes | Q73716600 | ||
| Neither LKB1 nor AMPK are the direct targets of metformin | Q80212438 | ||
| Insulin Resistance Prevents AMPK-induced Tau Dephosphorylation through Akt-mediated Increase in AMPKSer-485 Phosphorylation | Q35905362 | ||
| Hypothermia-induced hyperphosphorylation: a new model to study tau kinase inhibitors | Q36067364 | ||
| Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models | Q36328476 | ||
| Adenosine monophosphate-activated protein kinase overactivation leads to accumulation of α-synuclein oligomers and decrease of neurites | Q36604979 | ||
| Methods for measuring tau pathology in transgenic mouse models | Q36768791 | ||
| Neuroprotective effects of adenosine monophosphate-activated protein kinase inhibition and gene deletion in stroke | Q37087368 | ||
| The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Aβ oligomers through Tau phosphorylation | Q37200468 | ||
| Role of 5'-adenosine monophosphate-activated protein kinase in cell survival and death responses in neurons. | Q37780209 | ||
| Multiple Defects in Energy Metabolism in Alzheimers Disease | Q37788708 | ||
| Function of the master energy regulator adenosine monophosphate-activated protein kinase in stroke | Q38086798 | ||
| Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons | Q38342193 | ||
| Glucose regulates amyloid β production via AMPK. | Q38864538 | ||
| The binding and phosphorylation of Thr231 is critical for Tau's hyperphosphorylation and functional regulation by glycogen synthase kinase 3beta | Q40097597 | ||
| Regulation of AMP-activated protein kinase by multisite phosphorylation in response to agents that elevate cellular cAMP. | Q40223208 | ||
| Pin1 allows for differential Tau dephosphorylation in neuronal cells | Q40280535 | ||
| Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. | Q41423732 | ||
| Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state | Q41525580 | ||
| Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. | Q42654706 | ||
| Conformational changes specific for pseudophosphorylation at serine 262 selectively impair binding of tau to microtubules | Q43273610 | ||
| Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. | Q43759003 | ||
| AMP-activated protein kinase is highly expressed in neurons in the developing rat brain and promotes neuronal survival following glucose deprivation | Q43772807 | ||
| Mitotic-like tau phosphorylation by p25-Cdk5 kinase complex | Q44491452 | ||
| Detection of Phosphorylated Ser262 in Fetal Tau, Adult Tau, and Paired Helical Filament Tau | Q46127208 | ||
| cAMP-dependent protein kinase phosphorylations on tau in Alzheimer's disease. | Q48128979 | ||
| Rescue of impaired late-phase long-term depression in a tau transgenic mouse model. | Q48166125 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 26758 | |
| P577 | publication date | 2016-05-27 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo | |
| P478 | volume | 6 |
| Q60950124 | AMP-activated Protein Kinase Controls Immediate Early Genes Expression Following Synaptic Activation Through the PKA/CREB Pathway |
| Q90599555 | AMPK Signaling Regulates the Age-Related Decline of Hippocampal Neurogenesis |
| Q38998405 | AMPK in Neurodegenerative Diseases |
| Q92970102 | Adiponectin Protects Against Cerebral Ischemic Injury Through AdipoR1/AMPK Pathways |
| Q90432920 | Adiponectin and Cognitive Decline |
| Q47132179 | An AMPK-dependent regulatory pathway in tau-mediated toxicity. |
| Q91542980 | Autophagy induction in the treatment of Alzheimer's disease |
| Q91629943 | Bayesian integrative analysis of epigenomic and transcriptomic data identifies Alzheimer's disease candidate genes and networks |
| Q99578886 | Circuitry and Synaptic Dysfunction in Alzheimer's Disease: A New Tau Hypothesis |
| Q38741861 | Current and future therapies for addressing the effects of inflammation on HDL cholesterol metabolism |
| Q39316849 | Energy Homeostasis and Abnormal RNA Metabolism in Amyotrophic Lateral Sclerosis |
| Q59791740 | Loss of Ca/Calmodulin Dependent Protein Kinase Kinase 2 Leads to Aberrant Transferrin Phosphorylation and Trafficking: A Potential Biomarker for Alzheimer's Disease |
| Q90094424 | Metabolic aspects of neuronal degeneration: From a NAD+ point of view |
| Q64066919 | Neuronal AMP-activated protein kinase hyper-activation induces synaptic loss by an autophagy-mediated process |
| Q33770234 | Nutritional and Pharmacological Strategies to Regulate Microglial Polarization in Cognitive Aging and Alzheimer's Disease. |
| Q91291806 | Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer |
| Q91644474 | Prospective of managing impaired brain insulin signalling in late onset Alzheimers disease with excisting diabetic drugs |
| Q90288934 | Protein Phosphatase 2A as a Drug Target in the Treatment of Cancer and Alzheimer's Disease |
| Q89411641 | Recent Insights on Alzheimer's Disease Originating from Yeast Models |
| Q90252848 | Research Progress on Alzheimer's Disease and Resveratrol |
| Q90152657 | The Bewildering Effect of AMPK Activators in Alzheimer's Disease: Review of the Current Evidence |
| Q92993163 | mTOR/AMPK signaling in the brain: Cell metabolism, proteostasis and survival |
Search more.